Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

m.com/wt/page/event_calendar" target="_new">http://www.onyx-pharm.com/wt/page/event_calendar

or by dialing 847-413-3235 and using the passcode 22274059. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 22274059 approximately one hour after the teleconference concludes. The replay will be available through September 4, 2008.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other cancers. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding sales trends and commercial activities and the timing, progress and results of clinical development, regulatory filings and actions. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission under the heading "Risk Factors" for a more detailed description of such factors, as well as the Company's subsequen
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),al...ythatitexecuted,ajointventure(JV)agreementtoestabl...acDalian).TheJVwillresearch,develop,produce,andcom...tsexpertise,andexperienceindevelopingandcommercial...slanduserights,manufacturingfacilitiesand,establis...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC ),ale...systemsandservicesforthecommercial,industrialandre...sinessgrouphasbeenawardedacontractfromManhattanTor...safetylab(BSL-4)replacementfacilityattheU.S.ArmyMe...D)atFortDetrickinFrederick,Md. ,, ThenewUSAMRII...
(Date:11/24/2009)...BLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--Dow...setsofHylandSeeds,adivisionofThompsonsLimitedofBle...xpandDowAgroSciences,currentseedsbusinessasthecomp...2010 andDowAgroSciencesHerbicideTolerantTraitTech...inthenearfuture. ,, "Thisacquisitionbringstoget...
(Date:11/24/2009)...Iceland,November24/PRNewswire-FirstCall/--deCODE,g...alofallofits,"firstday"motionsbytheU.S.BankruptcyC...).deCODElastweekfiledavoluntarypetitionfor,reliefu...e,BankruptcyCourt. , TheordersissuedbytheBank...usinessduringtheChapter11proceedings.Inparticular,...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...CKVILLE, Md., May 6 Novavax, Inc. (Nasdaq:,NVAX) ... quarter financial,results in a press release to b...08. The Company will hold an investor conference c... Eastern Time on May 9, 2008. The call will,be hos...er Dr. Rahul,Singhvi and other members of senior m...
...rnings Conference Call to be held on May 28, 2008 ...) / 8:00 pm (Beijing/Hong Kong), SHANGHAI, China,...man),Inc. (NYSE: WX ), a leading pharmaceutical, ...lopment outsourcing company with operations in Chi...will release unaudited financial,results for the f...
...ards Honoring Mental Health Programs Supported by ...harmaceutical, Inc., ROCKVILLE, Md., May 6 The A...ee nonprofit organizations and one individual,as t...dvancing Minority,Mental Health. The awards were p...ton, D.C. Each organization or individual was pres...
Other Biology Technology:Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call 2WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:11/24/2009)... arteries from collapsing have been true life-save...er needed -- once the arteries are strengthened, t... choice but to leave them in place. , Prof. Meit...f Biomedical Engineering has developed a new paten...they,re needed, then dissolves. , "Our new compo...
(Date:11/24/2009)...4, 2009) -- The Wildlife Conservation Society (WCS... remaining population of Siberian tigers has likel... poaching and habitat loss. , WCS sa...f what needs to be done to protect remaining popul... The report was released by the Siberian Tiger Mo...
(Date:11/24/2009)...New research on bacterial communities throughout s...le temporal patterns, suggesting that scientists c...ng climate change in the polar regions. The study,...tional Academy of Sciences Early Edition, shows t...d synchronously over time, correlating with season...
Breaking Biology News(10 mins):A coating for life 2Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 1CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 2CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 3CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 4CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 5CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 6New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 1New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 1M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 2M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 4
...the phenomenon commonly called "red tide" is expec...r, according to researchers with the Woods Hole Oc...State University (NCSU). , This advisory is base...ies of Alexandrium fundyense the algae notori...s, mussels, and other shellfish and can cause para...
...TIL WEDNESDAY, APRIL 22, 2009; 2:00 AM U.S. EASTER...l Development (USAID) and the Wildlife Conservatio...nvironment Protection Agency (NEPA), which announc...internationally recognized national park., USAID ...on, including support of WCS to conduct preliminar...
...2007, an international team of researchers from Ch...ve of dinosaur skeletons from Early Cretaceous roc...e ancient Silk Road city of Jiayuguan, Gansu Provi... species of theropod dinosaurs, and both are descr...n the Proceedings of the Royal Society B this we...
Other Biology News:Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 2Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 3Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 4Afghanistan declares its first national park 2Field Museum paleontologist leads study on two new dinosaurs from China 2Field Museum paleontologist leads study on two new dinosaurs from China 3Field Museum paleontologist leads study on two new dinosaurs from China 4
...oduction demands on cell and tissue culture assume...ns. Therefore, both cell concentration and percent...and precisely. The new Vi-CELLTM Cell Viability An...ans to perform the trypan blue dye exclusion metho...
...vides a powerful yet simple technology for labelin...cids. The kit provides the heterobifunctional link...ng conjugation efficiencies. It enables conjugatio... biotin and other tags with a variety of proteins....
...ides the sensitivity and versatility you expect fr... photon counting with selected photomultipliers en...al demands. Equipped with up to 2 reagent injector...says as well as other luminescence applications in...
BD Falcon TufRol Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
Biology Products: